Thryvv : ratio page

Tatva Chintan Pharma

Overview Articles Financials Ratios Shareholding Peers

Financial Ratios

View
Order
Financial Ratios
Mar2025
Mar2024
Mar2023
Mar2022
Mar2021
Valuation Parameters:
PE(x)
278.00
83.19
81.23
53.35
0.00
PCE(x)
47.59
45.13
67.12
49.16
0.00
Price/Book(x)
2.15
3.43
7.18
10.81
0.00
EV/Net Sales(x)
4.21
6.36
9.02
11.66
0.35
EV/Core EBITDA(x)
43.82
32.95
57.43
43.03
1.46
EV/EBIT(x)
177.15
49.73
71.57
46.25
1.61
EV/CE(x)
2.08
3.33
5.58
8.53
0.41
MCap / Sales
4.15
6.42
8.72
11.80
0.00
Growth Ratio:
Net Sales Growth(%)
-2.74
-7.11
-2.31
44.38
14.10
Core EBITDA Growth(%)
-51.58
14.10
-43.40
63.52
26.86
EBIT Growth(%)
-81.93
-5.77
-51.19
67.87
25.60
PAT Growth(%)
-81.18
-33.27
-52.56
83.45
38.30
EPS Growth(%)
-81.18
-36.77
-52.56
66.26
-44.68
Financial Stability Ratios:
Total Debt/Equity(x)
0.05
0.02
0.33
0.25
0.54
Current Ratio(x)
2.76
3.74
1.31
2.54
1.52
Quick Ratio(x)
1.37
1.82
0.63
1.55
0.95
Interest Cover(x)
6.01
7.47
6.21
20.90
14.65
Operational & Financial Ratios:
Earnings Per Share (Rs)
2.44
12.98
20.52
43.25
26.02
CEPS(Rs)
14.27
23.92
24.83
46.95
29.37
DPS(Rs)
1.00
2.00
2.00
2.00
5.00
Book NAV/Share(Rs)
315.84
315.10
232.25
213.44
82.62
Tax Rate(%)
24.62
30.33
-1.58
7.92
13.90
Margin Ratios:
Core EBITDA Margin(%)
8.99
17.33
14.34
25.01
22.17
EBIT Margin(%)
2.37
12.75
12.60
25.20
21.66
Pre Tax Margin(%)
1.98
11.04
10.57
24.00
20.18
PAT Margin (%)
1.49
7.69
10.73
22.10
17.38
Cash Profit Margin (%)
8.71
14.18
12.99
23.98
19.62
Performance Ratios:
ROA(%)
0.70
3.91
6.53
19.68
18.21
ROE(%)
0.77
4.85
9.21
30.01
36.85
ROCE(%)
1.19
7.00
8.35
25.75
28.04
Asset Turnover(x)
0.47
0.51
0.61
0.89
1.05
Sales/Fixed Asset(x)
0.69
1.10
2.03
2.67
2.30
Working Capital/Sales(x)
2.26
1.81
5.76
1.64
4.54
Efficiency Ratios:
Fixed Capital/Sales(x)
1.44
0.91
0.49
0.37
0.43
Receivable days
72.59
71.34
60.72
61.98
85.15
Inventory Days
136.58
145.79
143.16
101.78
82.27
Payable days
71.30
80.91
61.91
86.25
94.96